Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Application symbols : AGNPF save search
Algernon Pharmaceuticals Announces Notice of Allowance for Method of Use U.S. Patent Application
Published: 2023-04-17 (Crawled : 19:00) - biospace.com/
AGNPF | $0.089 178.69% 75K
|
Health Technology
|
| O: -1.08%
H: 12.66%
C: 4.75%
patent pharmaceuticals application
Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent Application for Idiopathic Pulmonary Fibrosis
Published: 2022-01-28 (Crawled : 12:00) - biospace.com/
AGNPF | $0.089 178.69% 75K
|
Health Technology
|
| O: -0.15%
H: 2.6%
C: -1.72%
als fibrosis application patent
Algernon Pharmaceuticals Announces Receipt of CAD$2M Cash Refund from Australian Research Program and Files Application to List its Common Shares on Nasdaq Capital Market
Published: 2021-10-21 (Crawled : 13:00) - biospace.com/
AGNPF | $0.089 178.69% 75K
|
Health Technology
|
| O: -1.64%
H: 11.67%
C: 8.0%
application australia research
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.